ImmunoPrecise Antibodies Set To Begin Trading On Nasdaq December 30

ImmunoPrecise Antibodies (TSXV: IPA) (NASDAQ: IPA) has officially been approved for listing on the Nasdaq Global Markets. The company announced the news this morning, indicating that it will trade under the same symbol that Canadian shareholders are accustomed to, “IPA”.

Trading of ImmunoPrecise’s shares on the Nasdaq is expected to commence on December 30. The company is also expected to remain listed on the TSX Venture exchange as well, under its current symbol.

The announcement follows the firm filing the application for such listing back in September. At the time, the company indicated that it was motivated for the dual listing as a result of the desire to gain greater exposure to both retail and institutional investors in the United States as well as internationally.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

ImmunoPrecise Antibodies last traded at $14.76 on the TSX Venture.


Information for this analysis was found via Sedar and ImmunoPrecise Antibodies Ltd. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Red Cloud Fall Mining Showcase 2026 | Day 2

More Gold Without a Bigger Upfront Bill? | Keith Boyle – New Found Gold

The Red Cloud Fall Mining Showcase 2026 | Day 1

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

ImmunoPrecise Begins Path to NASDAQ

This morning ImmunoPrecise Antibodies Ltd (TSXV: IPA) announced they have commenced the application process to...

Thursday, September 10, 2020, 09:45:18 AM

ImmunoPrecise Insider Sells $1.9 Million Worth Of Shares Over Three Days

ImmunoPrecise Antibodies Ltd (TSXV: IPA) has seen continued insider selling over the last several days....

Wednesday, September 16, 2020, 12:17:00 PM

Paul Andreola: ImmunoPrecise & Stock Picking In The Small Cap Arena – The Daily Dive

In this episode, we sat down with Paul Andreola, from Smallcap Discoveries, whom is also...

Monday, August 9, 2021, 01:30:00 PM

Market Movers: Canadian Small Cap COVID-19 Stocks Take A Beating

COVID-19 related stocks are all the rage this morning, however it appears to be for...

Monday, November 9, 2020, 10:56:07 AM

ImmunoPrecise Begins Pre-Clinical Trials For SARS-CoV-2 Vaccine

ImmunoPrecise Antibodies (TSXV: IPA) and its partner LiteVax BV jointly announced this morning that they...

Friday, September 25, 2020, 08:30:35 AM